Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Nylænde, M
Right arrow Articles by Seljeflot, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nylænde, M
Right arrow Articles by Seljeflot, I
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Peripheral Arterial Disease
*Vasculitis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease

M Nylænde

Department of Vascular Surgery, Aker University Hospital, Oslo, Norway, marthe{at}nylaende.com, ingebjorg.seljeflot{at}uus.no

A Kroese

Department of Vascular Surgery, Aker University Hospital, Oslo, Norway

E Stranden

Department of Vascular Diagnosis and Research, Aker University Hospital, Oslo, Norway

B Morken

Department of Vascular Diagnosis and Research, Aker University Hospital, Oslo, Norway

G Sandbæk

Department of Radiology, Aker University Hospital, Oslo, Norway

AK Lindahl

Department of Vascular Surgery, Aker University Hospital, Oslo, Norway

H Arnesen

Center for Clinical Research, Ullevål University Hospital, Oslo, Norway, Department of Cardiology, Ullevål University Hospital, Oslo, Norway

I Seljeflot

Center for Clinical Research, Ullevål University Hospital, Oslo, Norway

The importance of inflammation in atherosclerosis is well established in cardiovascular disease. However, limited data exist on the relationship between vascular inflammation and the severity of peripheral arterial occlusive disease (PAD). We investigated the relationship between biochemical markers of vascular inflammation and the diagnostic measures of PAD: ankle-brachial pressure index (ABI), maximum treadmill walking distance and angiographic score. In 127 patients (mean age 66 years; 64% males) with angiographically verified PAD, fasting blood samples were drawn for determination of selected soluble cell adhesion molecules, cytokines and chemokines. Tumor necrosis factor-{alpha} (TNF{alpha}), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) and CD40 ligand (CD40L) were all significantly correlated with the angiographic score (p < 0.05 for all). After adjustment for relevant co-variates, MCP-1 and CD40L remained statistically significant (p < 0.01 for both). IL-6 was, independent of other risk factors, inversely correlated with the maximum treadmill walking distance (p < 0.01). Our cross-sectional study in PAD patients showed that the vascular inflammatory markers MCP-1, CD40L and IL-6 were significantly associated with the extent of atherosclerosis, assessed by angiographic score and maximum treadmill walking distance. These findings indicate that vascular inflammation is implicated in PAD, which might be of importance in future diagnosis and treatment of the disease.

Key Words: Angiography • ankle-brachial pressure index • cytokines • peripheral arterial occlusive disease • treadmill walking distance • vascular inflammation

Vascular Medicine, Vol. 11, No. 1, 21-28 (2006)
DOI: 10.1191/1358863x06vm662oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Vasc MedHome page
F. J Khawaja and I. J Kullo
Novel markers of peripheral arterial disease
Vascular Medicine, November 1, 2009; 14(4): 381 - 392.
[Abstract] [PDF]


Home page
Vasc MedHome page
M. Nylaende, A.J. Kroese, B. Morken, E. Stranden, G. Sandbaek, A.K. Lindahl, H. Arnesen, and I. Seljeflot
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
Vascular Medicine, November 1, 2007; 12(4): 275 - 283.
[Abstract] [PDF]


Home page
Vasc MedHome page
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam
An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease
Vascular Medicine, November 1, 2007; 12(4): 299 - 309.
[Abstract] [PDF]